Ductal lavage may not detect breast cancer

October 19, 2004

Ductal lavage is not an effective method for detecting breast cancer, according to a new study led by researchers at Northwestern Memorial Hospital that appears in the October 20 issue of the Journal of the National Cancer Institute.

"This study raises serious questions about the utility of ductal lavage as a cancer detection test and shows us that women should not be offered ductal lavage as a method of breast cancer detection. Mammography and physical examination remain the most effective methods of early detection," explains the study's lead author Seema Khan, M.D., interim director of the Lynn Sage Comprehensive Breast Center and surgeon at Northwestern Memorial Hospital. Dr. Khan adds that "ductal lavage does remain promising as a method for obtaining more information about the level of breast cancer risk."

Ductal lavage is a method that can be used to collect cells that have been shed from the lining of milk ducts from the breast of healthy women, and then examined for early abnormalities. However, it is feasible only when fluid can be expressed from the ducts. On average, only 1 or 2 ducts of the 6-8 that are present in a normal breast will produce fluid. Ductal lavage has been proposed as a screening tool for cancer detection because ducts that yield fluid were thought to be more likely to contain cancer cells. Interest in the procedure was spurred by a study in which ductal lavage detected cancer in four of 11 women who had shown no previous evidence of a malignancy.

To determine the sensitivity and specificity of ductal lavage in the presence of known breast cancer, researchers conducted a pilot study in which ductal lavage was performed prior to mastectomy on 44 breasts from 32 women with known cancer and on eight breasts from seven women undergoing prophylactic mastectomy.

The researchers found poor agreement between a cytologic (cell) analysis of the cells from ductal lavage and results from looking at breast tissue under the microscope. In breasts with cancer, ductal lavage was able to detect only about half of the cancers, possibly because ducts that contain cancer failed to yield fluid or yielded cells classified as benign or mildly atypical. In addition, ducts that produced fluid did not appear to be related to the cancer in about half of the cancer-containing breasts.

In an accompanying editorial, Carol J. Fabian, M.D., of the University of Kansas Medical Center in Kansas City, and colleagues review several other ongoing studies that are attempting to evaluate the utility of ductal lavage. Based on the results of the current study, they conclude, ductal lavage cannot be considered a sensitive screening tool. "Its use as a risk assessment tool and/or as an indicator of response to [a prevention] intervention is still undergoing evaluation," they write.
-end-
About Northwestern Memorial Hospital
Northwestern Memorial Hospital (NMH) is one of the country's premier academic medical centers and is the primary teaching hospital of Northwestern University's Feinberg School of Medicine. Northwestern Memorial and its Prentice Women's Hospital and Stone Institute of Psychiatry have 744 beds and more than 1,200 affiliated physicians and 5,000 employees. Providing state-of-the-art care, NMH is recognized for its outstanding clinical and surgical advancements in such areas as cardiothoracic and vascular care, gastroenterology, neurology and neurosurgery, oncology, organ and bone marrow transplantation, and women's health.

Northwestern Memorial was ranked as the nation's 5th best hospital by the 2002 Consumer Checkbook survey of the nation's physicians and is listed in eight specialties in this year's US News & World Report's issue of "America's Best Hospitals." NMH is also cited as one of the "100 Best Companies for Working Mothers" by Working Mother magazine and has been chosen by Chicagoans year after year as their "most preferred hospital" in National Research Corporation's annual survey.

Northwestern Memorial HealthCare

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.